advertisement
11.3.3 Apraclonidine, brimonidine (2)
Showing records 1 to 2
Display all abstracts in classification 11.3.3 Apraclonidine, brimonidine
Search within classification 11.3.3 Apraclonidine, brimonidine26671 Brimonidine hypersensitivity when switching between 0.2% and 0.15% formulations
Sullivan-Mee M; Pensyl D; Alldredge B; Halverson K; Gerhardt G; Qualls C
Journal of Ocular Pharmacology and Therapeutics 2010; 26: 355-360
26348 Meta-analysis of the efficacy and safety of alpha2-adrenergic agonists, beta-adrenergic antagonists, and topical carbonic anhydrase inhibitors with prostaglandin analogs
Tanna AP; Rademaker AW; Stewart WC; Feldman RM
Archives of Ophthalmology 2010; 128: 825-833
